Bone Density Conservation Agents

"Bone Density Conservation Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

Descriptor ID	D050071
MeSH Number(s)	D27.505.696.242
Concept/Terms	Bone Density Conservation Agents Bone Density Conservation Agents Antiresorptive Agents Antiresorptive Agents Bone Resorption Inhibitors Inhibitors, Bone Resorption Resorption Inhibitors, Bone Bone Resorption Inhibitory Agents Antiresorptive Drugs

Below are MeSH descriptors whose meaning is more general than "Bone Density Conservation Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Bone Density Conservation Agents [D27.505.696.242]

Below are MeSH descriptors whose meaning is more specific than "Bone Density Conservation Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bone Density Conservation Agents" by people in this website by year, and whether "Bone Density Conservation Agents" was a major or minor topic of these publications.

Bar chart showing 38 publications over 12 distinct years, with a maximum of 7 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	2	0	2
2006	6	1	7
2007	1	1	2
2008	3	1	4
2009	4	0	4
2010	2	3	5
2011	2	2	4
2013	4	0	4
2014	1	0	1
2017	2	0	2
2018	2	0	2
2020	1	0	1

Below are the most recent publications written about "Bone Density Conservation Agents" by people in Profiles.

Jacobson DL, Lindsey JC, Gordon C, Hazra R, Spiegel H, Ferreira F, Amaral FR, Pagano-Therrien J, Gaur A, George K, Benson J, Siberry GK. Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age. Clin Infect Dis. 2020 08 22; 71(5):1281-1288.

View in: PubMed
Duryea J, Gravallese EM, Wortman JR, Xu C, Lu B, Kay J, Solomon DH. Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide. Scand J Rheumatol. 2021 Jan; 50(1):11-14.

View in: PubMed
Ayyoub S, Coyne C. VISUAL VIGNETTE. Endocr Pract. 2018 Nov; 24(11):1020.

View in: PubMed
Jategaonkar AA, Badhey AK, Sokoya M, Kadakia S, Mudrovich S, Ducic Y. Total mandibulectomy defect in the setting of chronic bisphosphonate use. Am J Otolaryngol. 2018 Sep - Oct; 39(5):649-651.

View in: PubMed
Solomon DH, Kay J, Duryea J, Lu B, Bolster MB, Yood RA, Han R, Ball S, Coleman C, Lo E, Wohlfahrt A, Sury M, Yin M, Yu Z, Zak A, Gravallese EM. Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Rheumatol. 2017 09; 69(9):1741-1750.

View in: PubMed
Sattari M, Cauley JA, Garvan C, Johnson KC, LaMonte MJ, Li W, Limacher M, Manini T, Sarto GE, Sullivan SD, Wactawski-Wende J, Beyth RJ. Osteoporosis in the Women's Health Initiative: Another Treatment Gap? Am J Med. 2017 08; 130(8):937-948.

View in: PubMed
D?ez-P?rez A, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Wyman A, Rushton-Smith SK, Watts NB. Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res. 2014 Jan; 29(1):260-7.

View in: PubMed
Gehlbach S, Hooven FH, Wyman A, Diez-Perez A, Adachi JD, Luo X, Bushmakin AG, Anderson FA. Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS One. 2013; 8(12):e82840.

View in: PubMed
Zhang J, Delzell E, Curtis JR, Hooven F, Gehlbach SH, Anderson FA, Saag KG. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass. Osteoporos Int. 2014 Jan; 25(1):317-24.

View in: PubMed
Kilgore ML, Outman R, Locher JL, Allison JJ, Mudano A, Kitchin B, Saag KG, Curtis JR. Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial. Osteoporos Int. 2013 Oct; 24(10):2555-60.

View in: PubMed

People

Explore

Similar Concepts

Top Journals